vimarsana.com
Home
Live Updates
A class of diabetes medications may reduce the risk of colorectal cancer : comparemela.com
A class of diabetes medications may reduce the risk of colorectal cancer
A groundbreaking study by researchers at Case Western Reserve University suggests a class of medications used to treat type 2 diabetes may also reduce the risk of colorectal cancer (CRC).
Related Keywords
United States ,
American ,
Rong Xu ,
Nathan Berger ,
Case Western Reserve School Of Medicine ,
Case Western Reserve University ,
National Institutes Of Health ,
Case Comprehensive Cancer Center ,
American Cancer Society ,
School Of Medicine ,
Western Reserve ,
Hanna Payne Professor ,
Experimental Medicine ,
Case Western Reserve School ,
Case Comprehensive Cancer ,
National Institutes ,
Cancer ,
Olorectal ,
Colorectal Cancer ,
Diabetes ,
Flood ,
Drugs ,
Glp 1 ,
Glucagon ,
Glucagon Like Peptide 1 ,
Insulin ,
Medicine ,
Metformin ,
Obesity ,
Ncology ,
Eceptor ,
Research ,
Students ,
Type 2 Diabetes ,
comparemela.com © 2020. All Rights Reserved.